Anti-Human Abeta Therapeutic Antibody (Gantenerumab)
Recombinant monoclonal antibody to Abeta. Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease. A phase I clinical trial has been conducted in 2006/07. Gantenerumab is currently being evaluated in a prodromal Alzheimer's Disease population in the Scarlet Road study, a global phase II study of approximately 360 subjects in 100 centers in 15 countries.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-229 |
| Pricing | Inquiry |
| Host | Human |
| Target | Abeta |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | FuncS, IF, Neut, ELISA, FC, IP, ICC, IHC, Inhib |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |